• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength

    12/16/25 4:05:00 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care
    Get the next $SOLV alert in real time by email

    ST. PAUL, Minn., Dec. 16, 2025 /PRNewswire/ -- Solventum (NYSE:SOLV) announced today that it has achieved the Diamond Level Resiliency Badge from the Healthcare Industry Resilience Collaborative (HIRC), the highest recognition for supply chain strength in healthcare. This certification validates Solventum's MedSurg segment's ability to deliver critical healthcare products consistently, even during supply disruptions to help ensure uninterrupted patient care.

    Solventum Logo (PRNewsfoto/3M Healthcare US Opco  LLC)

    "The Diamond Level Resiliency Badge represents the highest standard in healthcare supply chain resiliency and operational maturity. Solventum's achievement demonstrates exceptional operational strength, risk management and the capability to support the continuity of patient care through every circumstance," said HIRC Executive Director Jesse Schafer.  

    The Diamond Level Badge is based on a rigorous, evidence-based assessment of resiliency across key domains, including demand planning, inventory management, logistics visibility, supplier management and risk mitigation. For customers, this certification underscores Solventum's commitment to reliability and proactive risk mitigation, giving them assurance that the team will work to support their needs, even in challenging circumstances.

    "Building resiliency has been a top priority since day one of our journey as Solventum," said Solventum Chief Supply Chain Officer Paul Harrington. "We've invested in visibility tools, risk management processes and contingency planning to make sure our customers have what they need, when they need it. This recognition validates the hard work of our teams and the systems we've put into place to keep care moving forward."

    Solventum received the Diamond Level Badge across all MedSurg product lines, including negative pressure wound therapy, advanced wound dressings, advanced skin care, IV site management, sterilization assurance, surgical solutions, hospital consumables and medical technologies OEM.

    "Since our spinoff, we've worked tirelessly to strengthen every link on our supply chain—from demand planning to supplier partnerships—because our patients cannot wait," said Brent Boucher, senior vice president for Solventum MedSurg Americas. "Achieving the Diamond Level Badge is proof that those efforts are paying off. It's not just a certification, it's a signal to our customers that we have the right team and infrastructure in place to navigate future challenges."

    About Solventum

    At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customers' toughest challenges, we pioneer game-changing innovations at the intersection of health, material and data science that change patients' lives for the better — while empowering healthcare professionals to perform at their best. See how at Solventum.com. 

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/solventum-earns-diamond-level-hirc-resiliency-badge-demonstrating-best-in-class-supply-chain-strength-302643936.html

    SOURCE Solventum

    Get the next $SOLV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SOLV

    DatePrice TargetRatingAnalyst
    1/26/2026$97.00Sector Weight → Overweight
    KeyBanc Capital Markets
    1/20/2026$100.00Neutral → Outperform
    Mizuho
    12/2/2025$100.00Neutral → Buy
    BTIG Research
    10/1/2025$77.00Neutral
    UBS
    9/11/2025$80.00Hold
    Jefferies
    7/15/2025$103.00Equal-Weight → Overweight
    Morgan Stanley
    7/1/2025$90.00Hold → Buy
    Argus
    6/6/2025Sector Weight
    KeyBanc Capital Markets
    More analyst ratings

    $SOLV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wendell Amy Mcbride bought $100,344 worth of shares (1,475 units at $68.03), increasing direct ownership by 41% to 5,039 units (SEC Form 4)

    4 - Solventum Corp (0001964738) (Issuer)

    3/11/26 6:31:11 AM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    $SOLV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Solventum to Participate in the 2026 KeyBanc Healthcare Forum

    ST. PAUL, Minn., March 11, 2026 /PRNewswire/ -- Solventum (NYSE:SOLV) announced today that management will participate in a virtual fireside chat at the KeyBanc Healthcare Forum on Wednesday, Mar. 18, 2026, beginning at approximately 10:30 a.m. EDT. More information about this event, including access to the live webcast and the webcast replay, will be available at investors.solventum.com.About SolventumAt Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customers' toughest chal

    3/11/26 4:05:00 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    Middleby Appoints Glenn Eisenberg To Board of Directors

    The Middleby Corporation (NASDAQ:MIDD), a global leader in the foodservice industry, today announced the appointment of Glenn Eisenberg to its Board of Directors, effective March 1. With the addition of Mr. Eisenberg, the Middleby Board expands to twelve members. "We are pleased to welcome Glenn Eisenberg to the Middleby Board. His deep experience will be an immediate asset as we execute our strategic transformation," said Tim FitzGerald, Middleby CEO. "Glenn has a proven 20-year track record of success as a public company CFO and senior operating executive across complex global manufacturing businesses. His expertise in financial discipline, industrial manufacturing, capital allocation,

    3/6/26 7:00:00 AM ET
    $LH
    $LMRI
    $MIDD
    Medical Specialities
    Health Care
    Industrial Machinery/Components
    Industrials

    Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year Guidance

    Reported sales decreased 3.7%; organic sales increased 3.5%Introduces full-year 2026 organic sales growth, adjusted EPS and free cash flow guidanceST. PAUL, Minn., Feb. 26, 2026 /PRNewswire/ -- Solventum (NYSE:SOLV) today reported financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 HighlightsSales of $2 billion decreased 3.7% on a reported basis; an increase of 3.5% on an organic basisGAAP diluted earnings per share of $0.36; adjusted diluted earnings per share of $1.57Operating cash flow of $96 million; free cash flow of $33 million"So

    2/26/26 4:05:00 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    $SOLV
    SEC Filings

    View All

    SEC Form 10-K filed by Solventum Corporation

    10-K - Solventum Corp (0001964738) (Filer)

    2/27/26 1:40:50 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    Solventum Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Solventum Corp (0001964738) (Filer)

    2/26/26 4:08:05 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Solventum Corporation

    SCHEDULE 13G/A - Solventum Corp (0001964738) (Subject)

    1/27/26 12:15:19 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    $SOLV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Solventum upgraded by KeyBanc Capital Markets with a new price target

    KeyBanc Capital Markets upgraded Solventum from Sector Weight to Overweight and set a new price target of $97.00

    1/26/26 8:32:07 AM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    Solventum upgraded by Mizuho with a new price target

    Mizuho upgraded Solventum from Neutral to Outperform and set a new price target of $100.00

    1/20/26 8:47:32 AM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    Solventum upgraded by BTIG Research with a new price target

    BTIG Research upgraded Solventum from Neutral to Buy and set a new price target of $100.00

    12/2/25 8:17:55 AM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    $SOLV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wendell Amy Mcbride bought $100,344 worth of shares (1,475 units at $68.03), increasing direct ownership by 41% to 5,039 units (SEC Form 4)

    4 - Solventum Corp (0001964738) (Issuer)

    3/11/26 6:31:11 AM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    Chief Supply Chain Officer Harrington Paul S converted options into 3,300 shares and covered exercise/tax liability with 1,073 shares, increasing direct ownership by 14% to 18,170 units (SEC Form 4)

    4 - Solventum Corp (0001964738) (Issuer)

    3/9/26 7:49:34 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    Chief Information Officer Landucci Amy converted options into 3,795 shares and covered exercise/tax liability with 1,731 shares, increasing direct ownership by 6% to 37,483 units (SEC Form 4)

    4 - Solventum Corp (0001964738) (Issuer)

    3/9/26 7:49:55 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    $SOLV
    Leadership Updates

    Live Leadership Updates

    View All

    Middleby Appoints Glenn Eisenberg To Board of Directors

    The Middleby Corporation (NASDAQ:MIDD), a global leader in the foodservice industry, today announced the appointment of Glenn Eisenberg to its Board of Directors, effective March 1. With the addition of Mr. Eisenberg, the Middleby Board expands to twelve members. "We are pleased to welcome Glenn Eisenberg to the Middleby Board. His deep experience will be an immediate asset as we execute our strategic transformation," said Tim FitzGerald, Middleby CEO. "Glenn has a proven 20-year track record of success as a public company CFO and senior operating executive across complex global manufacturing businesses. His expertise in financial discipline, industrial manufacturing, capital allocation,

    3/6/26 7:00:00 AM ET
    $LH
    $LMRI
    $MIDD
    Medical Specialities
    Health Care
    Industrial Machinery/Components
    Industrials

    Solventum Appoints Heather Knight as Chief Commercial Officer

    ST. PAUL, Minn., Oct. 21, 2025 /PRNewswire/ -- Solventum (NYSE:SOLV) announced today the appointment of Heather Knight as Chief Commercial Officer, effective November 10, 2025. In this newly created role, Ms. Knight will oversee global commercial and R&D operations across Solventum's MedSurg, Dental Solutions and Health Information Systems segments, and will report directly to CEO Bryan Hanson. Ms. Knight brings over 30 years of leadership experience in the MedTech industry. Most recently, she served as Chief Operating Officer at Baxter International, where she led global sale

    10/21/25 5:00:00 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    Ampersand Biomedicines Appoints Elizabeth Mily to Board of Directors

    BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Ampersand Biomedicines, a multi-product platform company developing smarter medicines that act specifically at the site of disease and nowhere else, today announced the appointment of Elizabeth Mily to its Board of Directors as Independent Director. A highly respected healthcare and financial industry veteran with more than 30 years of experience, Mily brings extensive expertise in corporate strategy, business development and investment leadership to Ampersand as it advances its Address, Navigate, Determine (AND)™ Platform to develop programmed biologics. "We are thrilled to welcome Elizabeth to Ampersand's Board as we leverage our AND Platform to

    2/11/25 8:00:00 AM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    $SOLV
    Financials

    Live finance-specific insights

    View All

    Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year Guidance

    Reported sales decreased 3.7%; organic sales increased 3.5%Introduces full-year 2026 organic sales growth, adjusted EPS and free cash flow guidanceST. PAUL, Minn., Feb. 26, 2026 /PRNewswire/ -- Solventum (NYSE:SOLV) today reported financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 HighlightsSales of $2 billion decreased 3.7% on a reported basis; an increase of 3.5% on an organic basisGAAP diluted earnings per share of $0.36; adjusted diluted earnings per share of $1.57Operating cash flow of $96 million; free cash flow of $33 million"So

    2/26/26 4:05:00 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    Solventum to Report Fourth Quarter and Full Year Fiscal 2025 Earnings on February 26, 2026

    ST. PAUL, Minn., Feb. 3, 2026 /PRNewswire/ -- Solventum (NYSE:SOLV) will release its fourth quarter fiscal 2025 financial results on Thursday, Feb. 26, 2026, after the U.S. financial markets close. Following the release, Solventum management will host a webcast to discuss the results and fiscal year 2026 outlook. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Date: Thursday, Feb. 26, 2026 Time: 3:30 p.m. CST / 4:30 p.m. EST Location: https://investors.solventum.com U.S. dial-in +1 (800) 715-9871 Internation

    2/3/26 4:05:00 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    Solventum Completes Acquisition of Acera Surgical

    Expands MedSurg portfolio into the fast-growing synthetic tissue matrices technology space in acute care settings in the U.S.Accelerates Solventum's business transformation through the acquisition of a strategically aligned asset in a technology adjacencyST. PAUL, Minn., Dec. 23, 2025 /PRNewswire/ -- Solventum (NYSE:SOLV) announced today it has completed the acquisition of Acera Surgical (Acera), a privately held bioscience company focused on developing and commercializing fully engineered materials for regenerative wound care. "Announcing and completing our first strategic ac

    12/23/25 4:05:00 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    $SOLV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Solventum Corporation

    SC 13G/A - Solventum Corp (0001964738) (Subject)

    11/12/24 5:47:11 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Solventum Corporation

    SC 13G/A - Solventum Corp (0001964738) (Subject)

    11/4/24 1:47:43 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care